Defibrillation testing is mandatory in patients with subcutaneous implantable cardioverter-defibrillator to confirm appropriate ventricular fibrillation detection

Jean-Benoit le Polain de Waroux*, Sylvain Ploux, Pierre Mondoly, Romain Eschalier, Marc Strik, Laura Houard, Bertrand Pierre, Samuel Buliard, Nicolas Klotz, Philippe Ritter, Michel Haissaguerre, Karim Mahfouz, Pierre Bordachar

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)642-650
Number of pages9
JournalHeart Rhythm
Volume15
Issue number5
DOIs
Publication statusPublished - 1 May 2018

Keywords

  • Complication
  • Defibrillation testing
  • Noise
  • Subcutaneous implantable cardioverter-defibrillator
  • Undersensing
  • RANDOMIZED-CONTROLLED-TRIAL
  • THERAPY
  • EXPERIENCE
  • EFFICACY
  • REGISTRY
  • SAFETY

Cite this